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Aims Women and men have different clinical presentations and outcomes in coronary artery disease (CAD). We tested
the hypothesis that sex differences may influence coronary atherosclerotic burden and coronary endothelial function
before development of obstructive CAD.
Methods
and results
A total of 142 patients (53 men, 89 women; mean+ SD age, 49.3+11.7 years) with early CAD simultaneously
underwent intravascular ultrasonography and coronary endothelial function assessment. Atheroma burden in the
left main and proximal left anterior descending (LAD) arteries was significantly greater in men than women
(median, 23.0% vs. 14.1%, P ¼ 0.002; median, 40.1% vs. 29.3%, P ¼ 0.001, respectively). Atheroma eccentricity in
the proximal LAD artery was significantly higher in men than women (median, 0.89 vs. 0.80, P ¼ 0.04). The
length of the coronary segments with endothelial dysfunction was significantly longer in men than women
(median, 39.2 vs. 11.1 mm, P ¼ 0.002). In contrast, maximal coronary flow reserve was significantly lower in
women than men (2.80 vs. 3.30, P, 0.001). Sex was an independent predictor of atheroma burden in the left
main and proximal LAD arteries (both P, 0.05) by multivariate analysis.
Conclusion Men have greater atheroma burden, more eccentric atheroma, and more diffuse epicardial endothelial dysfunction
than women. These results suggest that men have more severe structural and functional abnormalities in epicardial
coronary arteries than women, even in patients with early atherosclerosis, which may result in the higher incidence
rates of CAD and ST-segment myocardial infarction in men than women.
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Introduction
Coronary artery disease (CAD) is the leading cause of morbidity
and mortality in men and women in most developed nations.1
Women and men have been shown to have different clinical pre-
sentations, prevalence, and clinical outcomes of CAD.2,3 Men
present more often than women with ST-segment elevation myo-
cardial infarction and have a higher prevalence of CAD adjusted to
age.1,4–6 Women present more frequently than men, however, for
the evaluation of chest pain and are more frequently hospitalized
for it.2 In addition, women who have CAD, especially younger
women, have more adverse outcomes after myocardial infarction
and coronary artery bypass grafting surgery than men despite
their documented lower angiographic disease burden.7–9 These
findings indicate that sex may have an important influence on car-
diovascular physiology and pathology.10,11 Thus, these differences
may reflect a differential effect of sex on the pathogenesis of coro-
nary atherosclerosis.
Measurement of atheroma burden by intravascular ultrasono-
graphy (IVUS)12–16 and assessment of endothelial function17–20
are useful tools for evaluating early features of coronary athero-
sclerosis. Current study was designed to test the hypothesis that
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sex influences coronary atherosclerotic burden and coronary
endothelial function before the development of obstructive
CAD. We simultaneously investigated the sex differences in ather-
oma burden and coronary endothelial function in patients with
early coronary atherosclerosis.
Methods
Study subjects
All patients had been referred for coronary angiography by an
independent cardiologist for evaluation of CAD. From January 2001
to February 2007, patients without obstructive CAD (diameter
stenosis, ,30% by angiography) were prospectively enrolled in tests
of endothelial function at Mayo Clinic in Rochester, MN, USA. Exclu-
sion criteria for undergoing testing of endothelial function included
presence of myocardial infarction; uncontrolled hypertension; valvular
heart disease; cardiomyopathy; ejection fraction ,40%; significant
endocrine, hepatic, renal, or inflammatory disease; presentation with
acute coronary syndrome; or refusal to participate. The Mayo Clinic
Institutional Review Board approved the study, and informed
consent was obtained from all participants.
For the current study, a subset of the group undergoing coronary
endothelial function testing was selected to also undergo IVUS.
Patients who had IVUS were selected randomly and did not sign
a separate consent form for the IVUS study. Patients who had
previous percutaneous coronary intervention or coronary artery
bypass grafting surgery were further excluded for this study. Long-
acting nitrates or calcium-channel blockers were withheld for 48 h
before the study to allow assessment of baseline coronary physiology.
Patients’ demographic and laboratory data were obtained from the
medical records.
Endothelial function assessment
and coronary flow reserve
Coronary angiography was performed according to standard
techniques using the femoral artery approach. Coronary endothelial
function was assessed as previously described.21–22 Briefly, a
Doppler guidewire (0.014" diameter, FloWire; Volcano Corp.,
Rancho Cordova, CA, USA) within a 2.2-F coronary infusion catheter
(Ultrafuse; SciMed Life Systems, Maple Grove, MN, USA) was
advanced and positioned in the middle portion of the left anterior
descending (LAD) coronary artery. Velocity signals were obtained
instantaneously from the Doppler wire by an online fast Fourier
transform, and average peak velocity was determined. Intracoronary
bolus injections of incremental doses (18–60 mg) of adenosine
were administered until maximal hyperaemia was achieved, to evaluate
endothelium-independent microvascular coronary flow reserve (CFR).
CFR was calculated by dividing the average peak velocity after
adenosine injection by the average peak velocity at baseline.
Subsequently, to assess endothelium-dependent function, the
endothelium-dependent vasodilator acetylcholine was selectively
infused into the LAD artery for 3 min at increasing concentrations
(1026, 1025, and 1024 M) to obtain effective coronary concentrations
of 1028, 1027, and 1026 M, respectively. Coronary artery diameter and
average peak velocity were measured. After each infusion of acetyl-
choline, coronary blood flow was calculated from the Doppler-derived
time velocity integral and vessel diameter as follows:
p coronary artery diameter
2
 2
 average peak velocity
2
 
:
Reproducibility of the measurements from our laboratory is 8+3%.
Percentage diameter change in the mid-LAD artery was measured in
the segment 5 mm distal to the tip of the Doppler wire after each infu-
sion. According to our previous studies, we defined coronary epicar-
dial endothelial dysfunction as .20% diameter decrease in response
to the maximum dose of acetylcholine compared with the coronary
artery diameter measured during baseline angiography in the same
artery location.21 Total length of endothelial dysfunction was defined
as the sum of the lengths of all segments with endothelial dysfunction.
Finally, endothelium-independent epicardial coronary artery function
was determined by the change in coronary artery diameter in response
to intracoronary nitroglycerine bolus injection (100 mg).
Coronary artery diameter and length were measured off-line by an
independent investigator, who was unaware of the patient’s sex and
clinical characteristics, by using a quantitative coronary angiography
program (Medis Corp., Leiden, The Netherlands) as previously
described.23 The reproducibility of the measurements from our labora-
tory is 5+2%.
Intravascular ultrasonography examination
After the assessment of coronary endothelial function and CFR,
200 mg intracoronary nitroglycerine was given, and IVUS imaging was
performed according to previously described methods.23,24 A 2.9-F
IVUS catheter with electronic scanning (Volcano Corp.) was advanced
into the mid-distal LAD artery via a 0.014" guidewire, which was
exchanged for a Doppler guidewire, and motorized pullback was per-
formed at a speed of 0.5 to 1.0 mm/s. The IVUS image was recorded
for later off-line analysis. External elastic membrane (EEM) area and
lumen area were measured in the proximal, distal, and lesion sites of
each left main and proximal LAD artery (from ostium to branching
site of first diagonal) by an independent investigator blinded to the
clinical data and endothelial function test results.
Atheroma (plaque plus media) area was calculated as EEM area
minus lumen area. As previously recommended,25 percentage ather-
oma burden was calculated as: (atheroma area/EEM area)  100;
atheroma eccentricity was calculated as: (maximum2minimum ather-
oma thickness)/maximum atheroma thickness. The proximal and distal
site of each segment was selected as the image slice with the largest
atheroma burden within 5 mm of the proximal and distal ends of
each segment. The lesion site selected for analysis was the image
slice with the largest percentage atheroma burden in each entire
segment. Segments with poor image quality or large vessel diameter
exceeding the IVUS scale, very short segments, and severely tortuous
vessels were excluded from analysis.
Statistical analysis
Continuous variables were presented as mean+ SD for characteristics
with appropriately near-symmetrical distributions or as median (inter-
quartile range). Discrete data are presented as frequencies and percen-
tages. Sex comparisons were evaluated with the Student’s t-test, the
Mann–Whitney U-test, or the Pearson x2 test. Multiple regression
models were used to assess whether the differences between men
and women were independent of other risk factors. Log transform-
ations of glucose, triglyceride, and C-reactive protein (CRP) levels
were used because of their skewed distributions. Because of the
high correlation between body surface area (BSA) and sex (r ¼ 0.46,
P, 0.001), we standardized BSA values for men and women separ-
ately, such that the new variable had a mean of 0 and SD of 1
within each sex, and used that variable for modelling. Residual distri-
butions were inspected by normal probability plots; if the plot
showed clear deviation from normality, the base 2 log transform was
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applied to the end point and the residuals were inspected again. The
length of endothelial dysfunction was skewed because many patients
had a length of 0 mm; thus, a multiple regression model for the
length of endothelial dysfunction was analysed only in patients with
endothelial dysfunction. Covariates for the models were selected by
inspecting unadjusted linear associations. Variables significant at the
0.15 level were included in the model as potential confounders. All
other hypothesis tests had a 0.05 significance level. All tests were
two-sided.
Results
Patient characteristics and risk factors
Of the 638 patients who underwent endothelial function testing,
152 patients (23.8%) were randomly selected to also undergo
IVUS during the study period. Ten of these patients were excluded
on the basis of previous percutaneous coronary intervention;
therefore, the cohort comprised 142 patients [53 men (37%), 89
women (63%)] who had a mean+ SD age of 49.3+11.7 years.
The clinical characteristics of the patients are shown in Table 1.
Fifty-four women (61%) were postmenopausal, 20 of whom
(37%) were receiving hormone-replacement therapy before the
present study. Men were significantly younger than women
(45.2+11.0 vs. 51.7+11.5 years, P ¼ 0.001) and had lower high-
density lipoprotein cholesterol levels (41.48+ 10.33 vs. 57.98+
16.41 mg/dL, P, 0.001). Women had significantly larger body
mass index (30.14+6.78 vs. 28.23+4.42 kg/m2, P ¼ 0.04),
higher total cholesterol (190.44+37.57 vs. 175.28+ 36.48 mg/
dL, P ¼ 0.02) and CRP values [0.36 (0.14–0.90) vs. 0.16 (0.07–
0.40) mg/dL, P ¼ 0.01], and lower haemoglobin (12.96+ 1.11 vs.
13.98+ .04 g/dL, P, 0.001) and creatinine (0.91+0.13 vs.
1.10+ 0.21, P, 0.001) values. Other parameters shown in
Table 1 were not significantly different between men and women.
Intravascular ultrasonography findings
Some segments were excluded because of poor image quality (17
segments in the left main and three segments in the LAD arteries),
large vessel diameter exceeding the IVUS scale (18 segments in the
left main), very short segments (10 segments in the left main), or
severely tortuous vessels (three segments in the LAD). A total
of 97 IVUS findings in the left main artery (from 36 men and 61
women) and 136 IVUS findings in the proximal LAD artery
(from 48 men and 88 women) remained for analysis. The EEM
area, lumen area, and atheroma area of the lesion site in the left
main artery were significantly larger in men (all P, 0.05;
Table 2). Men also had significantly greater atheroma burden in
the proximal site, distal site, and lesion site of the left main
artery (all P, 0.05; Table 2, Figure 1A). In the proximal LAD
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Table 1 Patient characteristicsa
Characteristic Patients P-value
Men (n 5 53) Women (n 5 89)
Age (year) 45.2+11.0 51.7+11.5 0.001
Hypertension 30 (56.6) 44 (49.4) 0.41
Diabetes mellitus 3 (5.7) 10 (11.2) 0.27
Hyperlipidemia 32 (60.4) 54 (60.7) 0.74
Current smoking 8 (15.1) 10 (11.2) 0.20
Body mass index (kg/m2) 28.23+4.42 30.14+6.78 0.04
Mean arterial pressure (mmHg) 96.56+14.00 99.29+15.23 0.31
Ejection fraction (%) 65.18+4.28 64.10+5.62 0.24
Creatinine (mg/dL) 1.10+0.21 0.91+0.13 ,0.001
Haemoglobin (g/dL) 13.98+1.04 12.96+1.11 ,0.001
Glucose (mg/dL) 94 (89–101) 94 (86–104) 0.56
Total cholesterol (mg/dL) 175.28+36.48 190.44+37.57 0.02
LDL cholesterol (mg/dL) 106.73+32.08 109.09+33.10 0.68
HDL cholesterol (mg/dL) 41.48+10.33 57.98+16.41 ,0.001
Triglycerides (mg/dL) 129 (86–166) 98 (64–147) 0.05
C-reactive protein (mg/dL) 0.16 (0.07–0.40) 0.36 (0.14–0.90) 0.01
Medications
Aspirin 31 (58.5) 45 (50.6) 0.36
b-Blockers 17 (32.1) 28 (31.5) 0.94
ACE inhibitors 13 (24.5) 17 (19.1) 0.44
Calcium-channel antagonists 20 (37.7) 35 (39.3) 0.85
Lipid-lowering agents 23 (43.4) 35 (39.3) 0.63
ACE, angiotensin-converting enzyme; HDL, high-density lipoprotein; LDL, low-density lipoprotein.
aValues are no. of patients (%), mean+ SD, or median (interquartile range).
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artery, the EEM area and atheroma area of the lesion site were sig-
nificantly larger in men (both P, 0.001; Table 2). Men also had sig-
nificantly greater atheroma burden in the proximal site and lesion
site of the proximal LAD artery than women (both P , 0.01;
Table 2, Figure 1A). Atheroma eccentricity in the lesion site of
the proximal LAD artery was also significantly greater in men
than in women [0.89 (0.78–0.94) vs. 0.80 (0.70–0.93), P ¼ 0.04;
Table 2, Figure 1B].
Coronary endothelial function
assessment
After intracoronary infusion of acetylcholine, the percentage
change in mid-LAD artery diameter was similar between men
and women (Table 3). However, the total length of coronary seg-
ments with endothelial dysfunction was significantly longer in men
than in women [39.2 (0.0–71.6) vs. 11.1 (0.0–38.5) mm,
P ¼ 0.002; Table 3, Figure 2]. Even after correction for BSA, men
had significantly longer coronary artery segments with endothelial
dysfunction than women [17.9 (0.0–35.6) vs. 6.8 (0.0–22.6) mm/
m2, P ¼ 0.008; Table 3]. The percentage change in artery diameter
after intracoronary nitroglycerine infusion was not significantly
different by sex (Table 3).
Coronary microvascular function test
Microvascular endothelial-dependent function, assessed by percen-
tage change in coronary blood flow after intracoronary acetyl-
choline infusion, was not significantly different by sex (Table 3).
In contrast, endothelium-independent microvascular function,
assessed by maximal CFR after intracoronary adenosine infusion,
was significantly lower in women than in men (Table 3, Figure 3).
Independent predictors of atheroma
burden in left main and proximal left
anterior descending arteries
By univariate analysis, male sex, age, mean arterial pressure (per
10 mmHg), creatinine level (per 0.2 mg/dL), haemoglobin value,
and log2 triglyceride level were predictors of log2 atheroma
burden in the left main artery. Male sex, age, haemoglobin value,
and log2 triglyceride level were predictors of atheroma burden
in the proximal LAD artery by univariate analysis (Table 4). By
multivariate analysis, male sex was an independent predictor of
log2 atheroma burden in the left main artery fb-coefficient [95%
confidence interval (CI)], 0.50 (0.03–0.97), P ¼ 0.04g and ather-
oma burden in the proximal LAD artery [8.91 (2.52–15.30),
P ¼ 0.007] (Table 5).
Independent predictors of length
of endothelial dysfunction and
coronary flow reserve
Because the length of artery with endothelial dysfunction was
0 mm in 53 patients (37%), the multiple regression model for
the length of endothelial dysfunction was performed including
only patients with endothelial dysfunction (n ¼ 89). Male sex and
age were predictors of the length of the coronary segment with
endothelial dysfunction by univariate analysis (Table 4). By multi-
variate analysis, male sex almost reached statistical significance as
a predictor of the length of endothelial dysfunction [b-coefficient
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Table 2 Intravascular ultrasonography findings in the left main and proximal left anterior descending arteriesa
Location Left main artery P-value Proximal LAD artery P-value
Men (n 5 36) Women (n 5 61) Men (n 5 48) Women (n 5 88)
Proximal
EEM area (mm2) 24.2 (19.6–26.6) 19.7 (17.2–22.3) ,0.001 18.4 (16.2–20.2) 15.0 (12.9–16.8) ,0.001
Lumen area (mm2) 19.7 (15.5–23.2) 17.7 (15.8–19.6) 0.06 13.5 (11.7–15.4) 12.4 (10.0–14.2) 0.01
Atheroma area (mm2) 3.2 (1.8–5.0) 1.6 (1.1–2.9) 0.002 4.3 (2.1–6.0) 2.2 (1.1–3.6) ,0.001
Atheroma burden (%) 14.5 (8.4–20.5) 8.8 (5.6–14.8) 0.01 22.0 (11.8–34.3) 15.2 (8.1–23.9) 0.007
Distal
EEM area (mm2) 25.4 (21.2–27.5) 19.7 (18.0–21.9) ,0.001 16.8 (14.5–21.8) 15.3 (13.6–17.6) 0.01
Lumen area (mm2) 18.8 (16.9–22.0) 17.6 (15.8–19.0) 0.006 12.9 (10.3–16.1) 12.0 (10.0–14.4) 0.17
Atheroma area (mm2) 5.2 (1.9–8.3) 1.8 (1.2–3.7) 0.002 2.7 (1.4–7.5) 2.2 (1.3–4.6) 0.21
Atheroma burden (%) 19.4 (8.3–32.1) 9.4 (6.0–18.8) 0.02 18.4 (7.7–36.4) 17.9 (7.8–29.4) 0.56
Lesion
EEM area (mm2) 24.2 (20.0–27.1) 19.7 (17.4–22.1) ,0.001 17.1 (15.4–21.2) 15.1 (13.2–16.7) ,0.001
Lumen area (mm2) 18.3 (15.4–21.0) 16.7 (14.7–18.5) 0.03 10.3 (8.7–12.2) 10.4 (8.3–12.3) 0.63
Atheroma area (mm2) 5.8 (3.2–7.7) 2.8 (1.4–4.2) ,0.001 7.3 (4.8–8.7) 4.3 (2.3–6.2) ,0.001
Atheroma burden (%) 23.0 (14.3–32.4) 14.1 (8.1–21.8) 0.002 40.1 (30.3–49.7) 29.3 (18.2–42.4) 0.001
Atheroma eccentricity 0.91 (0.81–0.97) 0.90 (0.67–0.97) 0.24 0.89 (0.78–0.94) 0.80 (0.70–0.93) 0.04
EEM, external elastic membrane; LAD, left anterior descending artery.
aValues are median (interquartile range).
S.H. Han et al1362
(95% CI), 11.94 (20.45 to 24.33), P ¼ 0.059; Table 5]. Male sex,
age, sex-standardized BSA, and creatinine (per 0.2 mg/dL), haemo-
globin, log2 glucose, and log2 CRP values were predictors of log2
maximal CFR by univariate analysis (Table 4). Age (P ¼ 0.047),
sex-standardized BSA (P ¼ 0.002), log2 glucose concentration
(P ¼ 0.04), and log2 CRP value (P ¼ 0.049) were independent pre-
dictors of log2 maximal CFR by multivariate analysis (Table 5).
Discussion
To our knowledge, this is the first study to simultaneously investi-
gate atheroma burden, endothelial function, and microvascular
function by sex in patients with early coronary atherosclerosis.
Our study showed that men with early atherosclerosis had more
severe atheroma burden, more eccentric atheroma, and more
diffuse epicardial artery endothelial dysfunction than women. The
current study supports a potential mechanism for the differential
incidence and clinical presentations of CAD between men and
women.
Age-adjusted CAD incidence rate and sudden cardiac death rate
in men exceed those in women.1,5,26 In addition, men present
more often than women with ST-segment elevation myocardial
infarction.27,28 Women more frequently present with non-obstruc-
tive coronary arteries and non-Q-wave myocardial infarctions. In
addition, aggressive revascularization management strategies have
not been found to be effective in women, although they have a
clear benefit in men.3,29–31 However, the potential mechanism
for these differences in the clinical presentation of CAD is not
known.
Recent clinical studies indicated that the level of plaque and
plaque progression as measured by IVUS appeared to be related
to future cardiovascular events,12–15 and IVUS-measured changes
in atheroma burden was suggested as a surrogate cardiovascular
end point.16 Our IVUS findings were similar to coronary angio-
graphic findings in previous reports, which showed that women
had lower rates of obstructive CAD at angiography when evalu-
ated for symptoms suggestive of myocardial ischaemia.2 Recently,
Nicholls et al.32 reported that the atheroma volume in women
with angiographic CAD is less than in men, despite the presence
of more cardiovascular risk factors in women. Our study
extends this previous observation and demonstrates that the
difference in atheroma burden exists even at early stages of
disease. Moreover, the women in the current study had more
CAD risk factors in terms of age, body mass index, total choles-
terol level, haemoglobin value, and CRP levels. Even accounting
for different cardiovascular risk factors between sexes, male sex
was an independent predictor of atheroma burden in left main
and proximal LAD arteries by multivariate analysis. In addition,
our study demonstrated that the morphology of atheroma was
more eccentric in men than in women. Thus, our study shows
that in patients with early CAD, men have greater atheroma
burden and eccentric atheroma in coronary arteries than do
women.
These findings may have clinical implications. Virmani et al.33
previously reported that plaque rupture in patients with sudden
coronary death was more frequent in men and that plaque
erosion was more frequently found in young women. Our IVUS
findings that men with early atherosclerosis had more severe
atheroma burden and eccentric atheroma in coronary arteries
suggest that these characteristics may contribute to a higher rate
of plaque rupture.
Similar to anatomic findings such as atheroma burden measured
by IVUS, functional measurements such as endothelium-dependent
vasomotor function of the coronary and brachial arteries have
been shown to predict long-term cardiovascular risk, including
cardiac and cerebrovascular events.17–20 In previous human
studies, women had significantly improved flow-mediated dilator
response to hyperaemia as measured by high-resolution ultrasono-
graphy of the brachial artery.34,35 Our study showed that men had
significantly longer coronary segments with endothelial dysfunc-
tion. Thus, to our knowledge, this is the first study to show that
Figure 1 Atheroma burden and atheroma eccentricity in the
lesion site of coronary arteries by sex. (A) Atheroma burden
was significantly greater in men than women in both the left
main (P ¼ 0.002) and proximal left anterior descending (LAD)
arteries (P ¼ 0.001). (B) Atheroma eccentricity in the proximal
LAD artery was significantly greater in men than in women
(P ¼ 0.04), but values in the left main artery were similar
(P ¼ 0.24). Data are expressed as mean+ SEM.
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men have more segments with vascular injury and abnormal repair,
which are at risk for the development of atherosclerosis and future
cardiovascular events.
Taken together, our IVUS findings and results of functional
studies show that men have more severe structural and functional
abnormalities than women in epicardial coronary arteries. These
abnormalities may explain the higher prevalence of CAD and the
higher incidences of ST-segment elevation myocardial infarction
and sudden cardiac death due to plaque rupture in men.
Although sex was not an independent predictor of maximal CFR
by multivariate analysis, our study showed that women had signifi-
cantly lower maximal CFR than men. These results are consistent
with those of a previous report that showed women had slightly
lower coronary vasodilatory reserve even with normal coronary
angiographic results.36 The endothelial-independent microvascular
dysfunction was an independent predictor of adverse outcomes in
patients with mild CAD.37 A recent clinical study reported that
coronary microvascular dysfunction was not associated with
markers of inflammatory or endothelial cell activation in women
with chest pain in the absence of obstructive CAD.38 This result
is consistent with our current findings regarding the disparity
between epicardial endothelial function and microvascular
endothelial-independent function in women.38 It has been
suggested that the mechanism of myocardial ischaemia in women
may be localized to the microvascular coronary arteries and
that abnormal microvascular function may have prognostic impli-
cations.38–42 Our microvascular function results support these
observations.
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Table 3 Coronary epicardial and microvascular functiona
Measurement Men (n 5 53) Women (n 5 89) P-value
Epicardial endothelial-dependent function
Percentage change in mid-LAD diameter after acetylcholine IC 210.6 (226.0 to 21.3) 210.1 (222.4–0.4) 0.41
Length of the endothelial dysfunction (mm) 39.2 (0.0–71.6) 11.1 (0.0–38.5) 0.002
Length of endothelial dysfunction/BSA (mm/m2) 17.9 (0.0–35.6) 6.8 (0.0–22.6) 0.008
Epicardial endothelial-independent function
Percentage change in mid-LAD diameter after nitroglycerine IC 9.3 (2.5–20.4) 10.0 (0.0–18.7) 0.74
Microvascular endothelial-dependent function
Percentage change in CBF after acetylcholine IC 27.3 (222.5–98.7) 36.1 (29.8–82.7) 0.89
Microvascular endothelial-independent function
Maximal CFR after adenosine IC 3.30 (2.90–4.00) 2.80 (2.40–3.20) ,0.001
BSA, body surface area; CBF, coronary blood flow; CFR, coronary flow reserve; IC, intracoronary infusion.
LAD, left anterior descending artery.
aValues are median (interquartile range).
Figure 2 Graph shows the length of the coronary segments
with epicardial endothelial dysfunction after intracoronary acetyl-
choline infusion. The segments were significantly longer in men
than women (P ¼ 0.002). Data are expressed as mean+ SEM.
Figure 3 Maximal coronary flow reserve (CFR) after intracor-
onary infusion of adenosine was significantly decreased in women
compared with men (P, 0.001). Data are expressed as
mean+ SEM.
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Table 4 Predictors of atheroma burden in left main and proximal left anterior descending arteries, epicardial function, and microvascular function by univariate
analysisa
Parameter Log2 atheroma burden in left
main
Atheroma burden in proximal
LAD
Length of coronary segments
with endothelial dysfunction
Log2 maximal CFR
b (95% CI) P b (95% CI) P b (95% CI) P b (95% CI) P
Male sex 0.62 (0.23–1.01) 0.002 8.12 (2.80–13.44) 0.003 15.59 (3.76–27.42) 0.01 0.22 (0.10–0.34) ,0.001
Age (per year) 0.02 (0.001–0.04) 0.04 0.29 (0.07–0.52) 0.01 20.61 (21.14 to 20.08) 0.02 20.01 (20.01–0.003) 0.001
Diabetes mellitus 20.46 (21.18–0.26) 0.21 5.49 (23.40–14.37) 0.22 215.18 (234.03–3.86) 0.12 0.01 (20.20–0.23) 0.91
Current smoking 20.19 (20.76–0.37) 0.50 1.07 (26.88–9.00) 0.79 21.74 (219.59–16.11) 0.85 20.04 (20.23–0.15) 0.68
BSA (per 0.25 m2) 0.25 (0.04–0.47) 0.02 1.99 (20.81–4.78) 0.16 4.21 (22.94–10.81) 0.21 0.12 (0.06–0.19) ,0.001
Sex-standardized BSA 0.10 (20.11–0.31) 0.34 0.09 (22.57–2.76) 0.95 0.22 (26.01–6.45) 0.95 0.08 (0.02–0.14) 0.01
BMI (per 5 kg/m2) 0.09 (20.07–0.25) 0.26 20.15 (22.29–1.99) 0.89 22.10 (27.21–3.02) 0.42 0.01 (20.05–0.06) 0.85
MAP (per 10 mmHg) 0.18 (0.04–0.32) 0.01 0.19 (21.61–2.00) 0.83 23.38 (27.41–0.65) 0.10 –0.04 (20.08–0.01) 0.09
Creatinine (per 0.2 mg/dL) 0.28 (0.09–0.48) 0.005 2.50 (20.29–5.28) 0.08 1.26 (24.67–7.20) 0.67 0.07 (0.01–0.14) 0.03
Haemoglobin 0.32 (0.16–0.48) ,0.001 3.25 (1.09–5.41) 0.004 1.13 (24.26–6.52) 0.68 0.06 (0.01–0.12) 0.02
Log2 glucose 0.12 (20.51–0.76) 0.70 7.76 (20.85–16.36) 0.08 217.23 (235.79–1.33) 0.07 20.22 (20.43 to 20.02) 0.03
Total cholesterol (per 40 mg/dL) 20.01 (20.22–0.21) 0.96 20.10 (22.89–2.69) 0.94 0.17 (26.17–6.51) 0.96 20.01 (20.08–0.06) 0.80
LDL cholesterol (per 25 mg/dL) 20.01 (20.17–0.14) 0.87 20.27 (22.29–1.76) 0.80 0.71 (23.90–5.32) 0.76 0.01 (20.04–0.05) 0.83
HDL cholesterol (per 10 mg/dL) 20.08 (20.20–0.04) 0.20 20.62 (22.22–0.99) 0.45 21.85 (25.81–2.11) 0.36 20.02 (20.06–0.01) 0.22
Log2 triglyceride 0.28 (0.02–0.53) 0.03 3.25 (0.19–6.30) 0.04 1.40 (25.95–8.75) 0.71 0.01 (20.06–0.09) 0.76
Log2 CRP 0.03 (20.06–0.13) 0.48 0.77 (20.51–2.04) 0.24 20.51 (23.43–2.42) 0.73 20.03 (20.06 to 20.004) 0.02
BMI, body mass index; BSA, body surface area; CFR, coronary flow reserve; HDL, high-density lipoprotein; LAD, left anterior descending artery; LDL, low-density lipoprotein; MAP, mean arterial pressure.
aValues are b-coefficient [95% confidence interval (CI)].
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Table 5 Independent predictors of epicardial and microvascular function and atheroma burden in the left main and proximal left anterior descending arteries by
multivariable analysisa
Parameter Log2 atheroma burden in
left main artery
Atheroma burden in proximal
LAD
Length of coronary segments
with endothelial dysfunction
Log2 maximal CFR
b (95% CI) P b (95% CI) P b (95% CI) P b (95% CI) P
Male sex 0.50 (0.03–0.97) 0.04 8.91 (2.52–15.3) 0.007 11.9 (20.45–24.3) 0.059 0.11 (20.04–0.26) 0.13
Age (per year) 0.02 (0.003–0.04) 0.02 0.38 (0.15–0.60) 0.001 20.28 (20.87–0.31) 0.34 20.005 (20.011 to 20.00007) 0.047
MAP (per 10 mmHg) 0.14 (0.01–0.27) 0.03 21.50 (25.70–2.71) 0.48 20.01 (20.05–0.03) 0.59
Creatinine (per 0.2 mg/dL) 0.03 (20.19–0.25) 0.78 20.70 (23.74–2.34) 0.65 0.02 (20.05–0.10) 0.67
Haemoglobin 0.19 (0.02–0.36) 0.03 1.99 (20.31–4.30) 0.09 0.006 (20.05–0.06) 0.84
Log2 triglycerides 0.16 (20.08–0.39) 0.19 1.79 (21.14–4.72) 0.23
Uric acid 0.01 (20.11–0.13) 0.84 0.01 (20.03–0.05) 0.59
Log2 glucose 5.43 (22.78–13.6) 0.19 28.91 (229.9–12.2) 0.40 20.21 (20.41 to 20.01) 0.04
Diabetes mellitus 26.11 (227.2–15.0) 0.57
Sex-standardized BSA 0.10 (0.04–0.16) 0.002
Log2 CRP 20.03 (20.06 to 20.0002) 0.049
BSA, body surface area; CFR, coronary flow reserve; CRP, C-reactive protein; LAD, left anterior descending artery; MAP, mean arterial pressure.
aValues are b-coefficient [95% confidence interval (CI)].
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Older age was an independent predictor of atheroma burden in
the left main and proximal LAD arteries and of maximal CFR in our
study. In this study, women were on an average 6.5 years older
than men. Our results suggest that if we had enrolled more
older men, sex differences in these parameters might be more
clearly demonstrated.
The primary reason for the low incidence of CAD in premeno-
pausal women compared with age-matched men may be related to
the preventive effects of oestrogen, as was documented in animal
studies of the antiatherosclerotic, antioxidative, and anti-
inflammatory effects of oestrogen.43–45 One previous animal
study46 reported that basal release of nitric oxide from
endothelium-intact aortic rings was greater in female rabbits than
in male rabbits and was related to circulating oestradiol concen-
trations. Oestrogen administration in humans has been shown to
enhance acetylcholine-stimulated increases in coronary blood
flow.47 In addition, oestrogen decreases cellular hypertrophy,
smooth muscle cell migration, and lower collagen deposition in
response to injury, which may lead to thinner fibrous plaque
in women.48 In our study, we did not find significant differences
in coronary atheroma burden, endothelial function, or microvascu-
lar function between premenopausal women and postmenopausal
women (data not shown). In addition, there were no significant
differences in these parameters in postmenopausal women regard-
less of whether they were receiving oestrogen-replacement
therapy (ERT, n ¼ 20) or not (n ¼ 34). Variable postmenopausal
period, duration of ERT, and different starting ages of ERT after
menopause may affect our results. Therefore, our study further
suggests that the effects of long-term ERT on coronary atheroma
burden, endothelial function, and microvascular function in post-
menopausal women should be clarified in future large-scale clinical
studies.
Androgens have been shown to affect the expression of
atherosclerosis-related genes in men but not in women, perhaps
contributing to the sex-related differences in CAD prevalence.49
The variations in plasma sex hormones and receptor genes,
acting with endothelial and vascular smooth muscle factors, may
be potential links to the sex differences in vascular structure and
function in ischaemic heart disease. Sex differences in CAD also
may be caused by non-hormonal factors.50
The current study has several limitations. It is possible that the
extent of atheroma throughout the coronary tree is not uniform
and that the extent of plaque demonstrated in one cross-section
does not reflect the patient’s plaque burden in general.
However, men in our study had greater atheroma burden than
women in several different sites, such as the proximal, distal, and
lesion sites of the left main artery and the proximal and lesion
sites of the proximal LAD artery.
We also cannot exclude the possibility of referral bias. Since the
main goal of the study was to detect differences in atheroma,
endothelial function, and microvascular function between sexes,
however, we believe that the selection bias is minimal. Regarding
a sex-based referral bias for coronary angiography, more recent
studies have shown less of a sex-related difference in referral pat-
terns for coronary angiography than earlier studies.51–53 Another
limitation was the possibility of enrolling patients who had shown
near-normal results of coronary angiography. However, the
segments that were near normal by coronary angiography usually
had some degree of atheroma by the IVUS study. Therefore,
IVUS rather than coronary angiography may provide more detailed
information on the characteristics of atherosclerosis by sex. In this
study, we investigated only LAD territory, since it is the largest
artery and easier from a technical and risk standpoint; further
study in the left circumflex and right coronary arteries will be war-
ranted in the future. The analysis of several end points in this paper
increases the chance (above the nominal rate of 5%) that some sig-
nificant results reflect spurious associations.
In conclusion, the present study demonstrated that in early
atherosclerosis, men have greater atheroma burden, more
eccentric atheroma, and more diffuse epicardial endothelial dys-
function than women. These results suggest that men have more
severe structural and functional abnormalities in epicardial coron-
ary arteries than women, even in patients with early atherosclero-
sis. These factors may influence the higher incidence rates of CAD
and ST-segment myocardial infarction in men than women.
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